Skip to Main Content

Paper Details

An open label study of a novel immunosuppression intervention for the treatment of amyotrophic lateral sclerosis.
Amyotroph Lateral Scler Frontotemporal Degener
28
2018
Author NameAffiliation
David A SchoenfeldHarvard Chan School of Public Health, Massachusetts General Hospital
James D BerryMassachusetts General Hospital
  • 1 - 2

Datasets

Release 1.2